Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Jazz Pharmaceuticals Price to Sales Ratio 2010-2023 | JAZZ

Historical PS ratio values for Jazz Pharmaceuticals (JAZZ) over the last 10 years. The current P/S ratio for Jazz Pharmaceuticals as of April 24, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Jazz Pharmaceuticals P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-04-25 107.43 2.03
2023-12-31 123.00 $52.80 2.33
2023-09-30 129.44 $54.30 2.38
2023-06-30 123.97 $55.65 2.23
2023-03-31 146.33 $57.34 2.55
2022-12-31 159.31 $58.17 2.74
2022-09-30 133.29 $57.65 2.31
2022-06-30 156.01 $56.34 2.77
2022-03-31 155.67 $54.28 2.87
2021-12-31 127.40 $51.75 2.46
2021-09-30 130.21 $48.50 2.68
2021-06-30 177.64 $45.51 3.90
2021-03-31 164.37 $42.93 3.83
2020-12-31 165.05 $42.08 3.92
2020-09-30 142.59 $40.42 3.53
2020-06-30 110.34 $39.09 2.82
2020-03-31 99.74 $38.33 2.60
2019-12-31 149.28 $37.52 3.98
2019-09-30 128.14 $35.19 3.64
2019-06-30 142.56 $33.42 4.27
2019-03-31 142.95 $32.27 4.43
2018-12-31 123.96 $30.78 4.03
2018-09-30 168.13 $30.12 5.58
2018-06-30 172.30 $29.23 5.89
2018-03-31 150.99 $27.51 5.49
2017-12-31 134.65 $26.38 5.10
2017-09-30 146.25 $25.68 5.70
2017-06-30 155.50 $25.03 6.21
2017-03-31 145.13 $24.76 5.86
2016-12-31 109.03 $23.98 4.55
2016-09-30 121.48 $22.97 5.29
2016-06-30 141.31 $22.31 6.33
2016-03-31 130.55 $21.46 6.08
2015-12-31 140.56 $21.01 6.69
2015-09-30 132.81 $20.84 6.37
2015-06-30 176.07 $20.33 8.66
2015-03-31 172.79 $19.71 8.77
2014-12-31 163.73 $19.02 8.61
2014-09-30 160.56 $17.61 9.12
2014-06-30 147.01 $16.49 8.91
2014-03-31 138.68 $15.20 9.12
2013-12-31 126.56 $14.18 8.93
2013-09-30 91.97 $13.40 6.86
2013-06-30 68.73 $12.51 5.50
2013-03-31 55.91 $11.18 5.00
2012-12-31 53.25 $9.75 5.46
2012-09-30 57.00 $8.48 6.72
2012-06-30 45.01 $7.15 6.29
2012-03-31 48.47 $6.49 7.47
2011-12-31 38.63 $5.84 6.62
2011-09-30 41.50 $5.40 7.68
2011-06-30 33.35 $4.93 6.77
2011-03-31 31.85 $4.68 6.80
2010-12-31 19.68 $4.84 4.06
2010-09-30 10.73 $4.49 2.39
2010-06-30 7.83 $4.70 1.67
2009-12-31 7.88 $4.32 1.82
2009-09-30 8.02 $4.05 1.98
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.824B $3.834B
Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients. Other drugs in the company's neuroscience portfolio include' Sunosi, Epidiolex & Sativex. Epidiolex is approved for treating seizures associated with two rare & severe forms of epilepsy' Lennox-Gastaut syndrome & Dravet syndrome. Sativex is approved in the U.K. & Canada as a treatment for symptom improvement in adult patients with moderate-to-severe spasticity due to multiple sclerosis. Jazz's oncology portfolio includes two drugs' Defitelio for the treatment hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplantation & Vyxeos for the treatment of adults with two types of acute myeloid leukemia. It received approval for two new drugs' Zepzelca & Rylaze'.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $69.006B 28.36
Chugai Pharmaceutical (CHGCY) Japan $52.738B 22.90
Takeda Pharmaceutical (TAK) Japan $41.871B 6.78
Merck (MKGAF) Germany $20.467B 19.31
Astellas Pharma (ALPMY) Japan $17.138B 24.28
Sandoz Group AG (SDZNY) Switzerland $14.417B 0.00
Shionogi (SGIOY) Japan $14.386B 12.45
Neurocrine Biosciences (NBIX) United States $13.828B 57.43
United Therapeutics (UTHR) United States $11.153B 11.95
Catalent (CTLT) United States $10.126B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.608B 0.00
Ionis Pharmaceuticals (IONS) United States $6.187B 0.00
Revolution Medicines (RVMD) United States $5.861B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.232B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.072B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.015B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.886B 0.00
Indivior (INDV) United States $2.594B 12.06
Summit Therapeutics (SMMT) United States $2.519B 0.00
Corcept Therapeutics (CORT) United States $2.340B 23.66
Dyne Therapeutics (DYN) United States $2.153B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.946B 0.00
PTC Therapeutics (PTCT) United States $1.931B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.863B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.857B 11.00
Evotec AG (EVO) Germany $1.853B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.816B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.784B 18.44
Avadel Pharmaceuticals (AVDL) Ireland $1.600B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Ardelyx (ARDX) United States $1.496B 0.00
Soleno Therapeutics (SLNO) United States $1.314B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.268B 11.91
4D Molecular Therapeutics (FDMT) United States $1.241B 0.00
Pacira BioSciences (PCRX) United States $1.205B 11.99
Xencor (XNCR) United States $1.163B 0.00
Collegium Pharmaceutical (COLL) United States $1.160B 7.14
Centessa Pharmaceuticals (CNTA) United Kingdom $0.949B 0.00
Cronos Group (CRON) Canada $0.947B 0.00
Cassava Sciences (SAVA) United States $0.897B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.868B 0.00
Sage Therapeutics (SAGE) United States $0.841B 0.00
USANA Health Sciences (USNA) United States $0.841B 13.24
Relay Therapeutics (RLAY) United States $0.840B 0.00
Enliven Therapeutics (ELVN) United States $0.819B 0.00
ARS Pharmaceuticals (SPRY) United States $0.797B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.727B 0.00
Ocular Therapeutix (OCUL) United States $0.719B 0.00
Silence Therapeutics (SLN) United Kingdom $0.667B 0.00
ProKidney (PROK) United States $0.622B 0.00
Siga Technologies (SIGA) United States $0.616B 9.12
Lyell Immunopharma (LYEL) United States $0.586B 0.00
Savara (SVRA) United States $0.586B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.551B 0.00
Verve Therapeutics (VERV) United States $0.550B 0.00
OmniAb (OABI) United States $0.534B 0.00
Korro Bio (KRRO) United States $0.505B 0.00
Altimmune (ALT) United States $0.502B 0.00
Exscientia (EXAI) United Kingdom $0.499B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.445B 0.00
KalVista Pharmaceuticals (KALV) United States $0.437B 0.00
Larimar Therapeutics (LRMR) United States $0.412B 0.00
Lexeo Therapeutics (LXEO) United States $0.412B 0.00
Esperion Therapeutics (ESPR) United States $0.403B 0.00
Heron Therapeutics (HRTX) United States $0.398B 0.00
Tourmaline Bio (TRML) United States $0.395B 0.00
Organogenesis (ORGO) United States $0.393B 74.50
Corbus Pharmaceuticals Holdings (CRBP) United States $0.373B 0.00
Nature's Sunshine Products (NATR) United States $0.367B 20.55
Harrow (HROW) United States $0.363B 0.00
Bioventus (BVS) United States $0.329B 0.00
Lyra Therapeutics (LYRA) United States $0.312B 0.00
Fractyl Health (GUTS) United States $0.301B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.288B 0.00
Akebia Therapeutics (AKBA) United States $0.287B 0.00
Aquestive Therapeutics (AQST) United States $0.286B 0.00
Nanobiotix S.A (NBTX) France $0.278B 0.00
ESSA Pharma (EPIX) Canada $0.277B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.273B 0.00
Black Diamond Therapeutics (BDTX) United States $0.262B 0.00
Xeris Biopharma Holdings (XERS) United States $0.261B 0.00
Pyxis Oncology (PYXS) United States $0.259B 0.00
Nektar Therapeutics (NKTR) United States $0.253B 0.00
Metagenomi (MGX) United States $0.253B 0.00
Adherex Technologies (FENC) United States $0.246B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Conduit Pharmaceuticals (CDT) United States $0.232B 0.00
Foghorn Therapeutics (FHTX) United States $0.222B 0.00
Avita Medical (RCEL) United States $0.221B 0.00
Acrivon Therapeutics (ACRV) United States $0.215B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Prelude Therapeutics (PRLD) United States $0.213B 0.00
Telomir Pharmaceuticals (TELO) United States $0.206B 0.00
Galectin Therapeutics (GALT) United States $0.204B 0.00
Zevra Therapeutics (ZVRA) United States $0.198B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.197B 0.00
Profound Medical (PROF) Canada $0.195B 0.00
Century Therapeutics (IPSC) United States $0.192B 0.00
MediWound (MDWD) Israel $0.167B 0.00
Achieve Life Sciences (ACHV) Canada $0.156B 0.00
CytoDyn (CYDY) United States $0.147B 0.00
Regulus Therapeutics (RGLS) United States $0.145B 0.00
Incannex Healthcare (IXHL) Australia $0.143B 0.00
Elite Pharmaceuticals (ELTP) United States $0.135B 12.63
Amylyx Pharmaceuticals (AMLX) United States $0.127B 2.69
Karyopharm Therapeutics (KPTI) United States $0.127B 0.00
VAXART, INC (VXRT) United States $0.126B 0.00
Inotiv (NOTV) United States $0.120B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
GlycoMimetics (GLYC) United States $0.120B 0.00
Relmada Therapeutics (RLMD) United States $0.116B 0.00
Citius Pharmaceuticals (CTXR) United States $0.114B 0.00
OptiNose (OPTN) United States $0.104B 0.00
Eliem Therapeutics (ELYM) United States $0.101B 0.00
FibroGen (FGEN) United States $0.097B 0.00
Vivani Medical (VANI) United States $0.095B 0.00
ProPhase Labs (PRPH) United States $0.091B 0.00
AlloVir (ALVR) United States $0.090B 0.00
PMV Pharmaceuticals (PMVP) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Assertio Holdings (ASRT) United States $0.082B 6.66
Marinus Pharmaceuticals (MRNS) United States $0.079B 0.00
Tempest Therapeutics (TPST) United States $0.076B 0.00
Carisma Therapeutics (CARM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Journey Medical (DERM) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.84
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
Jaguar Animal Health (JAGX) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
JanOne (JAN) United States $0.041B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
Unicycive Therapeutics (UNCY) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.033B 0.00
Protara Therapeutics (TARA) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.031B 0.00
Nutriband (NTRB) United States $0.030B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
DURECT (DRRX) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Lipocine (LPCN) United States $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.73
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.10
CERo Therapeutics Holdings (CERO) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Addex Therapeutics (ADXN) Switzerland $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Traws Pharma (TRAW) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Cosmos Health (COSM) Greece $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.05